Inhibition of human platelet cyclic AMP phosphodiesterase and of platelet aggregation by a hemisynthetic flavonoid, amentoflavone hexaacetate. - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Biochemical Pharmacology Année : 1986

Inhibition of human platelet cyclic AMP phosphodiesterase and of platelet aggregation by a hemisynthetic flavonoid, amentoflavone hexaacetate.

Alain Beretz
F Briancon-Scheid
  • Fonction : Auteur
A Stierle
  • Fonction : Auteur
G Corre
  • Fonction : Auteur
R Anton
  • Fonction : Auteur

Résumé

Amentoflavone hexaacetate (AmAc) was synthesized from natural amentoflavone (Am), a biflavonoid extracted from Viburnum lantana L. Am does not inhibit aggregation of intact platelets up to a concentration of 100 microM but inhibits human platelet cAMP phosphodiesterase (IC50 = 22.0 microM). AmAc is a potent inhibitor of the aggregation of washed human platelets induced by ADP (IC50 = 2.3 microM) or collagen (IC50 = 4.7 microM). AmAc inhibits crude (IC50 = 8.6 microM) or partially purified (IC50 = 42.2 microM) human platelet cAMP phosphodiesterase. In the presence of prostaglandin E1, AmAc (10 microM) induces a 3.7-fold increase in total platelet cAMP. The characteristics of this action suggest a role for cAMP in the mechanism of action of AmAc. The incubation of AmAc with intact platelets for 5 min is necessary for its activity.
Fichier non déposé

Dates et versions

hal-02516548 , version 1 (23-03-2020)

Identifiants

  • HAL Id : hal-02516548 , version 1

Citer

Alain Beretz, F Briancon-Scheid, A Stierle, G Corre, R Anton, et al.. Inhibition of human platelet cyclic AMP phosphodiesterase and of platelet aggregation by a hemisynthetic flavonoid, amentoflavone hexaacetate.. Biochemical Pharmacology, 1986, 35 (2), pp.257-262. ⟨hal-02516548⟩

Collections

SITE-ALSACE
12 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More